Chemoinformaics analysis of INDOLE-3-CARBOXALDEHYDE
Molecular Weight | 145.161 | nRot | 1 |
Heavy Atom Molecular Weight | 138.105 | nRig | 11 |
Exact Molecular Weight | 145.053 | nRing | 2 |
Solubility: LogS | -2.563 | nHRing | 1 |
Solubility: LogP | 2.02 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 9 |
No. of Oxygen atom | 1 | No. of Arom Bond | 10 |
nHA | 1 | APOL | 21.5996 |
nHD | 1 | BPOL | 8.46045 |
QED | 0.611 |
Synth | 1.978 |
Natural Product Likeliness | 0.095 |
NR-PPAR-gamma | 0.04 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.004 |
HIA | 0.008 |
CACO-2 | -4.492 |
MDCK | 0.00000989 |
BBB | 0.899 |
PPB | 0.816419 |
VDSS | 1.172 |
FU | 0.191707 |
CYP1A2-inh | 0.977 |
CYP1A2-sub | 0.45 |
CYP2c19-inh | 0.559 |
CYP2c19-sub | 0.285 |
CYP2c9-inh | 0.12 |
CYP2c9-sub | 0.911 |
CYP2d6-inh | 0.081 |
CYP2d6-sub | 0.782 |
CYP3a4-inh | 0.105 |
CYP3a4-sub | 0.182 |
CL | 6.548 |
T12 | 0.798 |
hERG | 0.014 |
Ames | 0.095 |
ROA | 0.465 |
SkinSen | 0.878 |
Carcinogencity | 0.25 |
EI | 0.994 |
Respiratory | 0.977 |
NR-Aromatase | 0.669 |
Antiviral | No |
Prediction | 0.745935 |